About the platform
Cell Research Platformis the world's first molecular hydrogen translational research center. The clinical trial base is built through incorporating the inhalation of hydrogen and various indications to research hydrogen medicine. At present, research projects by more than 20 authoritative academicians have settled in the base and published papers. We plan to train 30 million practicing physicians so that they will be committed to the continuous development of the hydrogen industry, and fully support the study of molecular hydrogen medicine.
The research will help to apply the simple intervention method and measure to the areas of adjuvant therapy, elderly care, rehabilitation, sub-health, etc.
Molecular hydrogen is the smallest molecule known in nature, and it was regarded by the scientific community as the inert gas without biological effects. In 2007, Nature Medicine published a paper confirming that hydrogen inhalation can protect cerebral ischemia-reperfusion injury. As of now, nearly 1200 relevant papers have been published internationally confirming the biological effects of hydrogen, and involving 63 kinds of important human diseases.